Ionpath: Funding, Investors & Team (Sep 2026)
Ionpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies. Its imaging technology surpasses light microscopy to analyze whether the tissues are fresh, frozen, or FFPE that enable healthcare providers to provide a diagnosis of cancer for improving human health.
Ionpath has raised $18.0M across 2 funding rounds on record, the most recent a Corporate Round announced in May 2022.
Ionpath Company Profile and Key Stats
Latest funding round on record: May 2022.
Ionpath Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Ionpath raised $18.0M in an undisclosed round announced in Sep 2020.
1.7 years later, a Corporate Round was announced in May 2022 with no disclosed amount.
Ionpath Founders and Leadership Team
Contact details for the Ionpath team: 1 of 1 has an email address on file.
Start 14-day free trial →Ionpath Funding Compared to Other Biotechnology Startups
Funded Startups Like Ionpath in Biotechnology and Menlo Park
Companies Similar to Ionpath
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Ionpath Funding FAQs
What does Ionpath do?
Ionpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies. Its imaging technology surpasses light microscopy to analyze whether the tissues are fresh, frozen, or FFPE that enable healthcare providers to provide a diagnosis of cancer for improving human health.
How much funding has Ionpath raised?
Ionpath has raised $18.0M across 2 rounds on record.
When did Ionpath last raise funding?
Ionpath's most recent funding round on record was announced in May 2022. The amount was not disclosed.
Who is the CEO of Ionpath?
Sander Gubbens is listed as CEO at Ionpath.
Where is Ionpath headquartered?
Ionpath is based in Menlo Park, California, United States.
How many employees does Ionpath have?
Ionpath is in the 11-50 employee band.
About FundedIQ's Ionpath Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ionpath is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.